Liposome-Novel Drug Delivery Systems

Because liposomes are highly biocompatible, biodegradable, and immunogenicity-free, they are now thought to be the most widely employed nanocarriers for a variety of hydrophobic and hydrophilic compounds that have the potential to be active. Moreover, liposomes have demonstrated improved drug solubility, regulated dispersion, and surface modification ability for focused, extended, and sustained release. Liposomes can be thought of as having developed from traditional, long-circulating, immune-system-targeting liposomes to actively targeted liposomes that respond to stimuli based on their composition. Numerous liposomal-based drug delivery methods are presently clinically licensed to treat a variety of illnesses, including viral, fungus, and cancer infections; more liposomes have advanced to the stage of clinical trials. The structure, composition, preparation techniques, and clinical uses of liposomes are covered in this article.